Literature DB >> 24364596

Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.

Guoyun Li1, Chao Cai, Lingyun Li, Li Fu, Yuqing Chang, Fuming Zhang, Toshihiko Toida, Changhu Xue, Robert J Linhardt.   

Abstract

Heparin is a critically important anticoagulant drug that was contaminated with a persulfonated polysaccharide in 2008, resulting in a number of severe adverse reactions, some leading to death. Controversy remains as to the precise composition of the 2008 contaminant, and new information suggests that heparin may now be subject to adulteration with a new, difficult to detect, contaminant, N-sulfo oversulfated chondroitin sulfate. This study synthesizes this new potential contaminant and describes the use of radical depolymerization followed by liquid chromatography-mass spectrometry to detect N-sulfo oversulfated chondroitin sulfate and to confirm the structure of the 2008 contaminant as oversulfated chondroitin sulfate and not oversulfated heparan sulfate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24364596      PMCID: PMC3927312          DOI: 10.1021/ac403625a

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  21 in total

Review 1.  On-line coupling of electrokinetic chromatography and mass spectrometry.

Authors:  Govert W Somsen; Roelof Mol; Gerhardus J de Jong
Journal:  J Chromatogr A       Date:  2010-02-01       Impact factor: 4.759

2.  Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives.

Authors:  V D Nadkarni; T Toida; C L Van Gorp; R L Schubert; J M Weiler; K P Hansen; E E Caldwell; R J Linhardt
Journal:  Carbohydr Res       Date:  1996-08-26       Impact factor: 2.104

3.  Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin.

Authors:  Zhongping Xiao; Britney R Tappen; Mellisa Ly; Wenjing Zhao; Lauren P Canova; Huashi Guan; Robert J Linhardt
Journal:  J Med Chem       Date:  2010-12-17       Impact factor: 7.446

4.  Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes.

Authors:  Elena Vismara; Monica Pierini; Giuseppe Mascellani; Lino Liverani; Marcelo Lima; Marco Guerrini; Giangiacomo Torri
Journal:  Thromb Haemost       Date:  2010-02-02       Impact factor: 5.249

5.  Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates.

Authors:  Shiguo Chen; Guoyun Li; Nian Wu; Xin Guo; Ningbo Liao; Xingqian Ye; Donghong Liu; Changhu Xue; Wengang Chai
Journal:  Biochim Biophys Acta       Date:  2013-01-09

6.  Glycosaminoglycans are fragmented by hydroxyl, carbonate, and nitrogen dioxide radicals in a site-selective manner: implications for peroxynitrite-mediated damage at sites of inflammation.

Authors:  Eleanor C Kennett; Michael J Davies
Journal:  Free Radic Biol Med       Date:  2009-05-07       Impact factor: 7.376

7.  Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.

Authors:  Lingyun Li; Fuming Zhang; Joseph Zaia; Robert J Linhardt
Journal:  Anal Chem       Date:  2012-09-26       Impact factor: 6.986

8.  Orthogonal analytical approaches to detect potential contaminants in heparin.

Authors:  Marco Guerrini; Zhenqing Zhang; Zachary Shriver; Annamaria Naggi; Sayaka Masuko; Robert Langer; Benito Casu; Robert J Linhardt; Giangiacomo Torri; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

Review 9.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

Review 10.  Analysis and characterization of heparin impurities.

Authors:  Szabolcs Beni; John F K Limtiaco; Cynthia K Larive
Journal:  Anal Bioanal Chem       Date:  2010-09-03       Impact factor: 4.142

View more
  8 in total

1.  Keratan sulfate glycosaminoglycan from chicken egg white.

Authors:  Li Fu; Xiaojun Sun; Wenqin He; Chao Cai; Akihiro Onishi; Fuming Zhang; Robert J Linhardt; Zhangguo Liu
Journal:  Glycobiology       Date:  2016-02-21       Impact factor: 4.313

Review 2.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

3.  Elucidating the unusual reaction kinetics of D-glucuronyl C5-epimerase.

Authors:  Deepika Vaidyanathan; Elena Paskaleva; Troy Vargason; Xia Ke; Scott A McCallum; Robert J Linhardt; Jonathan S Dordick
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

4.  Vibrational Signatures of Isomeric Lithiated N-acetyl-D-hexosamines by Gas-Phase Infrared Multiple-Photon Dissociation (IRMPD) Spectroscopy.

Authors:  Yanglan Tan; Ning Zhao; Jinfeng Liu; Pengfei Li; Corey N Stedwell; Long Yu; Nicolas C Polfer
Journal:  J Am Soc Mass Spectrom       Date:  2017-01-03       Impact factor: 3.109

Review 5.  Bioengineered heparins and heparan sulfates.

Authors:  Li Fu; Matthew Suflita; Robert J Linhardt
Journal:  Adv Drug Deliv Rev       Date:  2015-11-10       Impact factor: 15.470

Review 6.  Tools for the Quality Control of Pharmaceutical Heparin.

Authors:  Anthony Devlin; Courtney Mycroft-West; Patricia Procter; Lynsay Cooper; Scott Guimond; Marcelo Lima; Edwin Yates; Mark Skidmore
Journal:  Medicina (Kaunas)       Date:  2019-09-25       Impact factor: 2.430

7.  Profiling pneumococcal type 3-derived oligosaccharides by high resolution liquid chromatography-tandem mass spectrometry.

Authors:  Guoyun Li; Lingyun Li; Changhu Xue; Dustin Middleton; Robert J Linhardt; Fikri Y Avci
Journal:  J Chromatogr A       Date:  2015-04-11       Impact factor: 4.759

Review 8.  Developments in Mass Spectrometry for Glycosaminoglycan Analysis: A Review.

Authors:  Lauren E Pepi; Patience Sanderson; Morgan Stickney; I Jonathan Amster
Journal:  Mol Cell Proteomics       Date:  2021-01-06       Impact factor: 5.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.